SJS From NSAIDs: California Claims for Severe Complications

What are SJS and related severe skin reactions?

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, severe reactions that typically involve blistering and detachment of skin and mucous-membrane involvement (often including the mouth and eyes). They can progress quickly and commonly require hospitalization and urgent specialty care. Medical background: MedlinePlus (NIH) — Stevens-Johnson syndrome; NORD — Stevens-Johnson syndrome.

Some patients experience long-term complications, which may include skin scarring or pigment changes and eye complications that can affect vision. Because SJS/TEN can have multiple triggers (including infections and multiple medications), prompt medical evaluation and careful investigation of potential causes is critical.

NSAIDs and SJS: why these cases can be complex

NSAIDs are commonly used to treat pain, inflammation, and fever. Product labeling for NSAIDs may warn about serious skin reactions, including SJS and TEN. For example, the FDA’s class Medication Guide for nonsteroidal anti-inflammatory drugs includes warnings about serious skin reactions (including SJS/TEN): FDA — Medication Guide: NSAIDs.

These cases can be medically and legally complex because:

• Timing matters: symptoms may begin after starting a medication, changing a dose, or intermittent over-the-counter use.
• Multiple exposures are common: patients may take other drugs around the same time (including drugs more commonly associated with SJS/TEN), complicating attribution.
• Underlying illness can be a confounder: infections and other conditions may overlap with early symptoms, and clinicians often must perform a differential diagnosis.

A thorough medication timeline and medical workup are often central to evaluating whether an NSAID is a plausible trigger in a specific case.

Potential California legal theories when SJS is linked to an NSAID

When an NSAID is alleged to have contributed to SJS/TEN, potential claims in California may involve product liability and, depending on the facts, negligence-based theories.

Failure to warn (inadequate warnings or labeling)

Failure-to-warn claims often focus on whether risk information was adequate and, for prescription drugs, whether warnings to prescribing clinicians were adequate under California’s learned intermediary framework. See Carlin v. Superior Court (1996) 13 Cal.4th 1104.

Manufacturing defect

If a particular lot or unit deviated from specifications (for example, contamination or incorrect dosage), that can support a manufacturing-defect theory. These cases often turn on batch records, recalls, quality control documentation, and product identification.

Design defect (often limited for prescription drugs)

In California, strict-liability design-defect claims for prescription drugs are generally barred (with limited exceptions) because such drugs are treated as “unavoidably unsafe” when properly prepared and accompanied by adequate warnings. See Brown v. Superior Court (1988) 44 Cal.3d 1049. Depending on the product (prescription vs. OTC) and the facts, plaintiffs sometimes explore alternative theories (including warning and manufacturing claims), but design-focused theories in drug cases are frequently contested and may be constrained by state and federal law.

Negligence and related claims (case-specific)

Depending on evidence, some cases also allege negligence theories (for example, unreasonable safety-monitoring practices or communications). Whether such claims are viable depends heavily on the specific facts, the defendant’s role, and any applicable defenses or federal preemption issues.

Important practical note: Drug product liability cases may also be shaped by federal preemption doctrine, especially for generic drugs (for example, limits on state-law claims premised on changing a generic label or design). See PLIVA, Inc. v. Mensing (2011) 564 U.S. 604 and Mutual Pharmaceutical Co. v. Bartlett (2013) 570 U.S. 472.

Causation: what evidence typically matters

In SJS/TEN cases, causation is often the central dispute. Attorneys and medical experts commonly look for:

• A detailed medication and symptom timeline (start/stop dates, dose changes, OTC products, supplements)
• Hospital and specialist records (including dermatology and ophthalmology)
• Documentation of differential diagnosis (other plausible causes considered and addressed)
• Any relevant history of drug reactions
• Product identification (exact product, manufacturer, lot information where available)

Because SJS/TEN can progress quickly, contemporaneous photographs and complete follow-up records can be important for documenting severity and long-term impact.

Severe complications and damages: what may be recoverable

If liability can be established, damages in California cases involving severe drug reactions may include (depending on proof and applicable law):

• Past and future medical costs (hospitalization, ICU/burn-unit care, surgeries, medications, rehabilitation)
• Specialist follow-up care (e.g., dermatology and ophthalmology)
• Lost income and reduced earning capacity
• Non-economic damages such as pain, suffering, and loss of enjoyment of life

In wrongful death matters, separate claims may be available to eligible family members. The categories and measurement of damages are fact-dependent and documentation-driven.

Who may be responsible (and who may not)

Depending on the facts, potential defendants may include entities in the distribution chain such as manufacturers and distributors, and sometimes retailers. Responsibility and defenses can be shaped by whether the NSAID was prescription-only or sold over the counter, whether the product was brand or generic, and how the warnings were intended to reach prescribers and consumers.

Separately, some situations raise questions about clinical care (for example, recognition of red-flag symptoms and whether a suspected offending drug was discontinued). Those issues, if present, are analyzed under different standards than a product liability claim and must be evaluated on their own facts.

Practical steps if you suspect SJS after taking an NSAID

Health and safety come first. If you suspect SJS/TEN or another severe skin reaction, seek urgent medical care immediately, especially with blistering, mucous-membrane involvement, eye symptoms, fever, or a rapidly spreading rash. Medical background: MedlinePlus.

• Tell clinicians every medication taken recently (prescription and OTC), including start dates and the last dose.
• Keep packaging/containers, receipts, and any remaining pills (do not take more). Photograph the label and any lot number if available.
• Request copies of key records (ER visit, hospitalization, discharge summary, dermatology/ophthalmology notes).
• Document the course with dated photos and a symptom journal if medically feasible.

From a legal perspective, early preservation of medication containers and records can be important to identify the correct product/manufacturer and evaluate what happened. For a California-specific intake, contact us.

Timing considerations in California

California statutes of limitations can apply to personal injury and wrongful death claims, and the applicable deadline can depend on the claim type and when the injury was (or reasonably should have been) discovered. See California Code of Civil Procedure § 335.1 (two-year limitations period for certain personal injury and wrongful death actions) and Jolly v. Eli Lilly & Co. (1988) 44 Cal.3d 1103 (discovery-rule principles in product/injury contexts).

Because severe drug reactions can involve evolving complications and uncertainty about the cause early on, it is often prudent to speak with counsel sooner rather than later to preserve evidence and assess options.

How a California SJS/NSAID case is typically investigated

An investigation commonly includes:

• Identifying the exact product (brand vs. generic), manufacturer, and pharmacy/purchase records
• Building a comprehensive medication timeline (including short-term OTC use)
• Reviewing labeling and warnings in effect at the time of use
• Reviewing medical records for diagnosis and differential diagnosis
• Consulting appropriate experts (often dermatology, pharmacology/toxicology, and ophthalmology)
• Evaluating alternative causes and competing medications

The goal is to assess whether the facts and science support a causal link and whether legal elements for a claim can be met under California law.

FAQ

Can an over-the-counter NSAID support a California claim?

Potentially, yes. The analysis depends on product identification, the warnings that applied at the time of use, the medical evidence of causation, and whether a viable legal theory fits the facts.

Does it matter if the NSAID was generic?

It can. Some claims involving generic drugs may be limited by federal preemption, depending on the theory and the case details. A product-specific review is usually necessary.

What should I do first if I think I have SJS/TEN?

Seek emergency medical care immediately. Then preserve medication packaging and obtain key medical records so the event can be accurately evaluated.

How do I start a California-specific evaluation?

Use our intake form or call through /contact to discuss what happened and what records to gather next.

California-specific disclaimer

This article is for general informational purposes only and is not legal advice. Reading this article or contacting us does not create an attorney-client relationship. Drug-injury cases are highly fact-specific, and outcomes depend on evidence, applicable California law, and potential federal preemption issues. If you believe you may be experiencing a medical emergency, call 911 or seek immediate medical care.

Call to action: If you or a family member suffered SJS/TEN after using an NSAID and want a California-specific review, contact us.